Complications of Cardiac Catheterization in Structural Heart Disease.
10.4070/kcj.2016.46.2.246
- Author:
Ko Eun LEE
1
;
Yeon Jeong SEO
;
Gi Beom KIM
;
Hyo Soon AN
;
Young Hwan SONG
;
Bo Sang KWON
;
Eun Jung BAE
;
Chung Il NOH
Author Information
1. Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea. ped9526@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Catheterization;
Complications;
Risk factors;
Heart diseases;
Catheters
- MeSH:
Anesthesia, General;
Body Weight;
Cardiac Catheterization*;
Cardiac Catheters*;
Catheterization;
Catheters;
Fluoroscopy;
Heart Diseases*;
Heart*;
Intensive Care Units;
Mortality;
Partial Thromboplastin Time;
Patient Selection;
Prothrombin Time;
Retrospective Studies;
Risk Factors;
Seoul
- From:Korean Circulation Journal
2016;46(2):246-255
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND AND OBJECTIVES: Cardiac catheterization is used to diagnose structural heart disease (SHD) and perform transcatheter treatment. This study aimed to evaluate complications of cardiac catheterization and the associated risk factors in a tertiary center over 10 years. SUBJECTS AND METHODS: Total 2071 cardiac catheterizations performed at the Seoul National University Children's Hospital from January 2004 to December 2013 were included in this retrospective study. RESULTS: The overall complication, severe complication, and mortality rates were 16.2%, 1.15%, and 0.19%, respectively. The factors that significantly increased the risk of overall and severe complications were anticoagulant use before procedure (odds ratio [OR] 1.83, p=0.012 and OR 6.45, p<0.001, respectively), prothrombin time (OR 2.30, p<0.001 and OR 5.99, p<0.001, respectively), general anesthesia use during procedure (OR 1.84, p=0.014 and OR 5.31, p=0.015, respectively), and total procedure time (OR 1.01, p<0.001 and OR 1.02, p<0.001, respectively). Low body weight (OR 0.99, p=0.003), severe SHD (OR 1.37, p=0.012), repetitive procedures (OR 1.7, p=0.009), and total fluoroscopy time (OR 1.01, p=0.005) significantly increased the overall complication risk. High activated partial thromboplastin time (OR 1.04, p=0.001), intensive care unit admission state (OR 14.03, p<0.001), and concomitant electrophysiological study during procedure (OR 3.41, p=0.016) significantly increased severe complication risk. CONCLUSION: Currently, the use of cardiac catheterization in SHD is increasing and becoming more complex; this could cause complications despite the preventive efforts. Careful patient selection for therapeutic catheterization and improved technique and management during the peri-procedural period are required to reduce complications.
